Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Maintains Outperform on Cree, Lowers Price Target to $115

Cowen & Co. analyst Jeff Osborne maintains Cree (NASDAQ:CREE) with a Outperform and lowers the price target from $150 to $115.

byBenzinga Newsdesk

August 16, 2021

1 minute read

Cowen & Co. analyst Jeff Osborne maintains Cree (NASDAQ:CREE) with a Outperform and lowers the price target from $150 to $115.

Barclays Initiates Coverage On Couchbase with Overweight Rating, Announces Price Target of $42

By Benzinga Newsdesk

Today, 4:53 AM

Barclays analyst Raimo Lenschow initiates coverage on Couchbase (NASDAQ:BASE) with a Overweight rating and announces Price Target of $42.

BASE

CFTC Chair Says Agency Did Not Receive Any Tips Or Whistleblowing Activity About FTX

By Benzinga Newsdesk

Today, 4:53 AM

-Reuters

COIN

Vir Biotechnology Gets Japan Emergency Approval For COVID Treatment

By Benzinga Newsdesk

Today, 4:53 AM

-Bloomberg

VIR

Dolphin Entertainment Announces Creation Of New Marketing And Consulting Agency Focused On Blockchain, Metaverse And Web3 Clients And Initiatives

By Benzinga Newsdesk

Today, 4:53 AM

Dolphin Entertainment, Inc. (NASDAQ:DLPN), a leading entertainment marketing and premium content production company, announced today the creation of a new marketing, consulting and communications agency focused solely on

DLPN

Cowen & Co. Maintains Outperform on Cree, Lowers Price Target to $115

Related Posts

Barclays Initiates Coverage On Couchbase with Overweight Rating, Announces Price Target of $42

CFTC Chair Says Agency Did Not Receive Any Tips Or Whistleblowing Activity About FTX

Vir Biotechnology Gets Japan Emergency Approval For COVID Treatment

Dolphin Entertainment Announces Creation Of New Marketing And Consulting Agency Focused On Blockchain, Metaverse And Web3 Clients And Initiatives